Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

Viatris

Status: Completed

Conditions: Depression/Depressed State

Treatments: Drug: venlafaxine

Study type: Observational

Funder types: Industry

Identifiers

NCT02958527

B2411278

Details and patient eligibility

About

SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE

Full description

This study will be conducted under the central registration system until the number of subjects who meet the conditions for registration reaches the target number of subjects. 12 weeks from the start date. The patients who completed the 12-week treatment with this product will be observed up until Week 52.

Enrollment: 1,408 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with no experience of using this product who will be administered this product for the first time

Exclusion criteria

• Exclusion criteria are not provided in this study

Trial design

1,408 participants in 1 patient group

venlafaxine

Description:

Patients with no experience of using time Effexor(venlafaxine) who will be administered time Effexor(venlafaxine)for the first

Treatment:

Drug: venlafaxine